PL2569007T3 - Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki - Google Patents

Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki

Info

Publication number
PL2569007T3
PL2569007T3 PL11720079T PL11720079T PL2569007T3 PL 2569007 T3 PL2569007 T3 PL 2569007T3 PL 11720079 T PL11720079 T PL 11720079T PL 11720079 T PL11720079 T PL 11720079T PL 2569007 T3 PL2569007 T3 PL 2569007T3
Authority
PL
Poland
Prior art keywords
administration
vaccine against
mycoplasma hyopneumoniae
derived antibodies
maternally derived
Prior art date
Application number
PL11720079T
Other languages
English (en)
Inventor
Maarten Hendrik Witvliet
Original Assignee
Intervet Int Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42667916&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2569007(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet Int Bv filed Critical Intervet Int Bv
Publication of PL2569007T3 publication Critical patent/PL2569007T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL11720079T 2010-05-11 2011-05-10 Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki PL2569007T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US33350210P 2010-05-11 2010-05-11
EP10162580 2010-05-11
PCT/EP2011/057463 WO2011141443A1 (en) 2010-05-11 2011-05-10 Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies
EP11720079.0A EP2569007B1 (en) 2010-05-11 2011-05-10 Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies

Publications (1)

Publication Number Publication Date
PL2569007T3 true PL2569007T3 (pl) 2016-04-29

Family

ID=42667916

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11720079T PL2569007T3 (pl) 2010-05-11 2011-05-10 Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki

Country Status (7)

Country Link
US (1) US20130064852A1 (pl)
EP (1) EP2569007B1 (pl)
JP (1) JP5865350B2 (pl)
DK (1) DK2569007T3 (pl)
ES (1) ES2559445T3 (pl)
PL (1) PL2569007T3 (pl)
WO (1) WO2011141443A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
CN104685057B (zh) * 2012-07-10 2019-04-16 海博莱科学有限公司 用于转化猪肺炎支原体的载体，转化的猪肺炎支原体菌株及其用途
WO2014176436A1 (en) 2013-04-24 2014-10-30 The General Hospital Corporation System and method for estimating high time-frequency resolution eeg spectrograms to monitor patient state

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994007531A1 (en) 1992-09-28 1994-04-14 Pfizer Inc Method of enhancing cell mediated immune responses
US6803041B2 (en) * 2001-03-20 2004-10-12 Boehringer Ingelheim Vetmedica, Inc. Equine herpesvirus vaccine
CN102872456B (zh) 2001-07-02 2016-01-20 硕腾服务有限责任公司 单剂量猪肺炎支原体疫苗
CA2463407C (en) 2001-10-12 2012-01-17 Felton International, Inc. Jet injector with hand piece
EP1515763B1 (en) 2002-06-10 2011-08-17 Intervet International BV Needle-less injector
UA84024C2 (ru) 2003-07-24 2008-09-10 Мериал Лимитед Новые вакцинные композиции, которые содержат эмульсию типа "масло в воде"
US7691368B2 (en) * 2005-04-15 2010-04-06 Merial Limited Vaccine formulations
AU2007222016A1 (en) * 2006-03-03 2007-09-13 Merial Limited Mycoplasma hyopneumoniae vaccine
EP2032163B1 (en) * 2006-06-15 2013-01-23 Novartis AG Adjuvant-sparing multi-dose influenza vaccination regimen
TWI449533B (zh) 2008-04-18 2014-08-21 Intervet Int Bv 防備胞內勞森菌（Ｌａｗｓｏｎｉａ ｉｎｔｒａｃｅｌｌｕｌａｒｉｓ）、豬肺炎黴漿菌（Ｍｙｃｏｐｌａｓｍａ ｈｙｏｐｎｅｕｍｏｎｉａｅ）及豬環狀病毒（Ｐｏｒｃｉｎｅ ｃｉｒｃｏ ｖｉｒｕｓ）用疫苗

Also Published As

Publication number Publication date
ES2559445T3 (es) 2016-02-12
JP5865350B2 (ja) 2016-02-17
EP2569007B1 (en) 2015-10-14
DK2569007T3 (en) 2016-01-25
JP2013526504A (ja) 2013-06-24
US20130064852A1 (en) 2013-03-14
WO2011141443A1 (en) 2011-11-17
EP2569007A1 (en) 2013-03-20

Similar Documents

Publication Publication Date Title
ZA201500784B (en) Mycobacterial antigen vaccine
PT2833908T (pt) Vacina de mycoplasma hyopneumoniae
ZA201308461B (en) Multiple antigen presenting immunogenic composition and methods and uses thereof
ZA201406974B (en) Pvc/mycoplasma hyopneumoniae combination vaccine
PL3513806T3 (pl) Imunogenna kompozycja
PT2809349T (pt) Composição imunogénica
PT3564378T (pt) Composição imunogénica
IL238079A0 (en) Immunogenic preparation
SG10201702685WA (en) Immunogenic composition
GB201223342D0 (en) Immunogenic composition
IL234604A (en) Carbon-glycophide vaccines are vaccinated
GB201218660D0 (en) Immunogenic composition
PL2569007T3 (pl) Szczepionka przeciwko Mycoplasma Hyopneumoniae, odpowiednia do podawania w obecności przeciwciał pochodzących od matki
EP2694102A4 (en) PROCESS FOR IMPROVED VACCINE IMMUNOGENICITY
SG11201505086QA (en) Immunogenic composition comprising mycoplasma antigens
EP2621530A4 (en) IMPROVED ADJUVANT SYSTEM FOR VACCINE DELIVERY
AU2012902151A0 (en) Immunogenic vaccines and uses thereof
IL228649B (en) Immunogenic preparations for use in treatment
GB201204968D0 (en) Immunogenic composition
GB201204851D0 (en) Immunogenic composition